New Products In Brief
This article was originally published in The Gray Sheet
New cancer companion diagnostic approved. Biotronik’s Ilesto 7 ICD and CRT-D earns FDA approval. More new product announcements.
You may also be interested in...
Roche's cobas EGFR Mutation Test v2 liquid biopsy test is approved to detect genetic mutations linked to drug response in patients with non-small cell lung cancer treated with Tarceva.
FDA has approved the first liquid biopsy test to detect genetic mutations linked to drug response in patients with non-small cell lung cancer. Roche's cobas EGFR Mutation Test v2 could be a game-changer in helping to diagnose certain NSCLC patients without requiring a tumor biopsy, the agency suggests.
The Ilesto Dx is the first of the small-sized Ilesto devices launched since their approval in May. Baxano expects modification of iO-Flex MicroBlade Shaver to be well-received during full launch. More product news.